Home LiteratureArticle Details
PMID: 19815530 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

CD4+ T cells control the differentiation of Gr1+ monocytes into fibrocytes.

Niedermeier M, Reich B, Rodriguez Gomez M, Denzel A, Schmidbauer K, Göbel N, Talke Y, Schweda F, Mack M

Abstract

Fibrocytes are collagen-type-I-producing cells that arise at low frequency from hematopoietic cells. We have analyzed in mice which leukocyte subsets are required for generation of fibrocytes and show that murine fibrocytes develop from the subpopulation of CD11b(+) CD115(+) Gr1(+) monocytes under the control of CD4(+) T cells. In the absence of CD4(+) T cells, differentiation of fibrocytes was markedly reduced in vitro and in vivo. In the presence of CD4(+) T cells, the characteristics of T-cell activation critically determined development of fibrocytes. Polyclonal activation of CD4(+) T cells induced the release of soluble factors that completely prevented the outgrowth of fibrocytes and could be identified as IL-2, TNF, IFN-gamma, and IL-4. Application of IL-2 and TNF significantly reduced the appearance of fibrocytes and the severity of fibrosis in the model of unilateral ureteral obstruction. In contrast, activation of CD4(+) T cells in the presence of calcineurin inhibitors, but not mTOR inhibitors, markedly enhanced the outgrowth of fibrocytes and renal deposition of collagen I. Taken together, we show that differentiation of fibrocytes is critically dependent on CD4(+) T cells and that the context of T-cell activation determines whether development of fibrocytes is supported or blocked. Our data may have implications for prevention of organ fibrosis in autoimmune diseases and transplantation.

MeSH Terms
Animals CD4-Positive T-Lymphocytes/immunology,physiology Cell Differentiation/immunology,physiology Cells, Cultured Collagen Type I/metabolism Cyclosporine/pharmacology Cytokines/antagonists & inhibitors,metabolism,pharmacology Female Fibrosis Immunosuppressive Agents/pharmacology Kidney/drug effects,immunology,pathology Mice Mice, Inbred BALB C Mice, Inbred C57BL Mice, SCID Monocytes/cytology,drug effects,immunology,metabolism Rats Rats, Inbred Lew Receptors, Chemokine/metabolism Sirolimus/pharmacology
Chemicals
Collagen Type I Cytokines Gr-1 protein, mouse Immunosuppressive Agents Receptors, Chemokine Cyclosporine Sirolimus
Authors & Affiliations
9 authors, click to expand affiliations / ORCID
Niedermeier Marianne
Department of Internal Medicine II, University Hospital Regensburg, 93042 Regensburg, Germany.
Reich Barbara
Rodriguez Gomez Manuel
Denzel Andrea
Schmidbauer Kathrin
Göbel Nicole
Talke Yvonne
Schweda Frank
Mack Matthias
References (42)
42 references, click to expand
  1. Ultrastructural evidence of dermal gadolinium deposits in a patient with nephrogenic systemic fibrosis and end-stage renal disease.
    Clin J Am Soc Nephrol. 2008 Jul;3(4):968-75 PMID: 18385397
  2. Nephrotoxicity of immunosuppressive drugs: new insight and preventive strategies.
    Curr Opin Crit Care. 2001 Dec;7(6):384-9 PMID: 11805539
  3. Stimulation of transforming growth factor-beta 1 transcription by cyclosporine.
    FEBS Lett. 1995 Jan 23;358(2):109-12 PMID: 7828718
  4. An IL-13 inhibitor blocks the development of hepatic fibrosis during a T-helper type 2-dominated inflammatory response.
    J Clin Invest. 1999 Sep;104(6):777-85 PMID: 10491413
  5. CCR2-mediated recruitment of fibrocytes to the alveolar space after fibrotic injury.
    Am J Pathol. 2005 Mar;166(3):675-84 PMID: 15743780
  6. Endothelial-to-mesenchymal transition contributes to cardiac fibrosis.
    Nat Med. 2007 Aug;13(8):952-61 PMID: 17660828
  7. Fibrocytes: a new insight into kidney fibrosis.
    Kidney Int. 2007 Aug;72(3):269-73 PMID: 17495856
  8. Renal fibrosis: collagen composition and assembly regulates epithelial-mesenchymal transdifferentiation.
    Am J Pathol. 2001 Oct;159(4):1313-21 PMID: 11583959
  9. Obstructive nephropathy: insights from genetically engineered animals.
    Kidney Int. 2005 Sep;68(3):925-37 PMID: 16105023
  10. Cyclosporine and long-term kidney graft survival.
    Transplantation. 2001 Oct 15;72(7):1267-73 PMID: 11602854
  11. Pericytes and perivascular fibroblasts are the primary source of collagen-producing cells in obstructive fibrosis of the kidney.
    Am J Pathol. 2008 Dec;173(6):1617-27 PMID: 19008372
  12. Calcineurin inhibitor nephrotoxicity: longitudinal assessment by protocol histology.
    Transplantation. 2004 Aug 27;78(4):557-65 PMID: 15446315
  13. Aggregated IgG inhibits the differentiation of human fibrocytes.
    J Leukoc Biol. 2006 Jun;79(6):1242-51 PMID: 16543402
  14. An IL-12-based vaccination method for preventing fibrosis induced by schistosome infection.
    Nature. 1995 Aug 17;376(6541):594-6 PMID: 7637808
  15. Bone marrow-derived progenitor cells in pulmonary fibrosis.
    J Clin Invest. 2004 Jan;113(2):243-52 PMID: 14722616
  16. Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis.
    J Clin Invest. 2004 Aug;114(3):438-46 PMID: 15286810
  17. Peripheral blood fibrocytes from burn patients: identification and quantification of fibrocytes in adherent cells cultured from peripheral blood mononuclear cells.
    Lab Invest. 2002 Sep;82(9):1183-92 PMID: 12218079
  18. Cyclosporine nephropathy: pathophysiology and clinical impact.
    Semin Nephrol. 1996 Nov;16(6):536-47 PMID: 9125798
  19. Differential regulation of transforming growth factor beta and interleukin 2 genes in human T cells: demonstration by usage of novel competitor DNA constructs in the quantitative polymerase chain reaction.
    J Exp Med. 1991 Nov 1;174(5):1259-62 PMID: 1682412
  20. Pivotal Advance: Th-1 cytokines inhibit, and Th-2 cytokines promote fibrocyte differentiation.
    J Leukoc Biol. 2008 Jun;83(6):1323-33 PMID: 18332234
  21. Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair.
    Mol Med. 1994 Nov;1(1):71-81 PMID: 8790603
  22. Cellular and molecular mechanisms of fibrosis.
    J Pathol. 2008 Jan;214(2):199-210 PMID: 18161745
  23. Inhibition of fibrocyte differentiation by serum amyloid P.
    J Immunol. 2003 Nov 15;171(10):5537-46 PMID: 14607961
  24. Interleukin-5 (IL-5) augments the progression of liver fibrosis by regulating IL-13 activity.
    Infect Immun. 2006 Mar;74(3):1471-9 PMID: 16495517
  25. Chronic allograft nephropathy.
    Curr Opin Nephrol Hypertens. 2008 Mar;17(2):149-55 PMID: 18277147
  26. Presence of CD45RO+ CD34+ cells with collagen synthesis activity in nephrogenic fibrosing dermopathy: a new pathogenic hypothesis.
    Br J Dermatol. 2004 May;150(5):1050-2 PMID: 15149539
  27. The IL-21 receptor augments Th2 effector function and alternative macrophage activation.
    J Clin Invest. 2006 Jul;116(7):2044-55 PMID: 16778988
  28. Chronic cyclosporine nephrotoxicity.
    Curr Opin Nephrol Hypertens. 1998 May;7(3):265-70 PMID: 9617556
  29. The controversial role of tumor necrosis factor alpha in fibrotic diseases.
    Arthritis Rheum. 2008 Aug;58(8):2228-35 PMID: 18668576
  30. Secondary lymphoid tissue chemokine (SLC/CCL21)/CCR7 signaling regulates fibrocytes in renal fibrosis.
    Proc Natl Acad Sci U S A. 2006 Sep 19;103(38):14098-103 PMID: 16966615
  31. Circulating peripheral blood fibrocytes in human fibrotic interstitial lung disease.
    Biochem Biophys Res Commun. 2007 Feb 2;353(1):104-8 PMID: 17174272
  32. The role of the fibrocyte, a bone marrow-derived mesenchymal progenitor, in reactive and reparative fibroses.
    Lab Invest. 2007 Sep;87(9):858-70 PMID: 17607298
  33. Nephrogenic systemic fibrosis: more questions and some answers.
    Nephron Clin Pract. 2008;110(1):c24-31; discussion c32 PMID: 18688172
  34. Bone marrow-derived cells do not contribute significantly to collagen I synthesis in a murine model of renal fibrosis.
    J Am Soc Nephrol. 2006 Mar;17(3):775-82 PMID: 16467445
  35. Obstructive nephropathy in the mouse: progressive fibrosis correlates with tubulointerstitial chemokine expression and accumulation of CC chemokine receptor 2- and 5-positive leukocytes.
    J Am Soc Nephrol. 2001 Jun;12(6):1173-1187 PMID: 11373340
  36. Identification of circulating fibrocytes as precursors of bronchial myofibroblasts in asthma.
    J Immunol. 2003 Jul 1;171(1):380-9 PMID: 12817021
  37. Transdifferentiation comes of age.
    Nephrol Dial Transplant. 2000 Nov;15(11):1729-31 PMID: 11071953
  38. Epithelial-mesenchymal transition and its implications for fibrosis.
    J Clin Invest. 2003 Dec;112(12):1776-84 PMID: 14679171
  39. Peripheral blood fibrocytes: differentiation pathway and migration to wound sites.
    J Immunol. 2001 Jun 15;166(12):7556-62 PMID: 11390511
  40. Anti-IL-4 treatment of Schistosoma mansoni-infected mice inhibits development of T cells and non-B, non-T cells expressing Th2 cytokines while decreasing egg-induced hepatic fibrosis.
    J Immunol. 1994 Jul 15;153(2):753-9 PMID: 8021510
  41. Regulated production of type I collagen and inflammatory cytokines by peripheral blood fibrocytes.
    J Immunol. 1998 Jan 1;160(1):419-25 PMID: 9551999
  42. Circulating fibrocytes: collagen-secreting cells of the peripheral blood.
    Int J Biochem Cell Biol. 2004 Apr;36(4):598-606 PMID: 15010326
Article Info
Journal
Proceedings of the National Academy of Sciences of the United States of America
Abbr.
Proc Natl Acad Sci U S A
ISSN
1091-6490
Published
2009-10-20
Epub
2009-00-06
Pages
17892-7
Language
English
Region
United States
NLM ID
7505876
PMCID
PMC2764893
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com